Fund moves

Procter & Gamble (PG): Robeco Institutional Asset Management B.V. added to its stake +57K shares

Robeco Institutional Asset Management B.V. added to its stake in Procter & Gamble, per its Q4 2025 13F.

1.47M
Shares reported · +57K vs prior quarter
0.30%
Disclosed portfolio weight
$211M
Reported value
Holdings as of
Dec 31, 2025
Filed
Jan 23, 2026

What stands out in this filing

  • 1,415,020 shares in Q3 2025, 1,472,125 now (+4.0% in share count).
  • Reported at $211M, 0.30% of the portfolio value in this 13F filing.
  • 89 other tracked managers reported the same kind of change for Q4 2025.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 16, 2025CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  2. Nov 5, 2025CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  3. Nov 13, 2025CongressDisclosed partial sale of PG — reported range $1,001 - $15,000
  4. Nov 18, 2025CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  5. Dec 1, 2025CongressDisclosed sale of PG — reported range $1,001 - $15,000
  6. Dec 15, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 9, 2025, Jennifer Davis, currently Chief Executive Officer - Health Care, notified the Company of her intent to retire effective June 30, 2026, after more than 33 years of service.”
  7. Dec 18, 2025CongressDisclosed sale of PG — reported range $1,001 - $15,000
  8. Dec 24, 2025CongressDisclosed partial sale of PG — reported range $1,001 - $15,000
  9. Jan 9, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  10. Jan 22, 2026Company filing · Form 8-K · ResultsReported its results
  11. Jan 23, 2026InsiderOfficer sold ~$14.5M of PG shares in the open market

What came next

  1. Jan 29, 2026CongressDisclosed sale of PG — reported range $1,001 - $15,000
  2. Jan 30, 2026CongressDisclosed partial sale of PG — reported range $1,001 - $15,000
  3. Feb 2, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  4. Feb 4, 2026InsiderCEO sold ~$1.26M of PG shares in the open market
  5. Feb 9, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  6. Feb 11, 2026Insider · 2 peopleInsiders: 2 sales (~$3.8M)
  7. Feb 12, 2026Insider · 2 peopleInsiders: 2 sales (~$32.2M)
  8. Feb 13, 2026Insider · Their largest sale since 2021Officer sold ~$2.46M of PG shares in the open market
  9. Feb 17, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  10. Feb 19, 2026InsiderOfficer sold ~$288K of PG shares in the open market
  11. Feb 26, 2026Congress · 2 peopleMembers of Congress: 2 sales
  12. Feb 27, 2026Insider · 1 personInsiders: 4 sales (~$917K)
  13. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  14. Apr 24, 2026Company filing · Form 8-K · ResultsReported its results
  15. Apr 27, 2026Congress · 1 personMembers of Congress: 2 purchases
  16. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Procter & Gamble

For Procter & Gamble, OQRO holds 40 insider filings (SEC Form 4 or Form 144), 9 Congress trade reports and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PG page.

How this filing works

Explore the data

Common questions

What does this filing report about Procter & Gamble (PG) stock?

Robeco Institutional Asset Management B.V. added to its stake in Procter & Gamble, per its Q4 2025 13F. Now 1.47M shares, $211M reported value, 0.30% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Dec 31, 2025. Filed: Jan 23, 2026.

What stands out in this filing?

1,415,020 shares in Q3 2025, 1,472,125 now (+4.0% in share count). Reported at $211M, 0.30% of the portfolio value in this 13F filing. 89 other tracked managers reported the same kind of change for Q4 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Procter & Gamble recently?

For Procter & Gamble, OQRO holds 40 insider filings (SEC Form 4 or Form 144), 9 Congress trade reports and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the PG page.

Does this mean PG stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Procter & Gamble

Everything OQRO holds on this company is on its PG page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data